undefined
EUTM file information

018199877


February 20, 2020

Trademark Summary

The trademark application was filed by SEPTODONT HOLDING, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on April 19, 2020, and it was registered by office on July 27, 2020 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on December 15, 2020. Appointment and Replacement of representative of the trademark registration was recorded on April 18, 2021. Change of name and address of the trademark registration was recorded on March 14, 2023.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical products namely, acne medication, allergy medication, antacids, anthelmintics, antiarrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medication, calcium channel blockers, central nervous system depressants, central nervous system stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives, pain relief medication, and topical and injectable pharmaceutical products for dental, endodontic and periodontal disorders
    2. Anti-epileptic pharmaceutical preparations
    3. Bismuth preparations for pharmaceutical use
    4. Bromine for pharmaceutical purposes
    5. Cardiovascular pharmaceutical preparations
    6. Frostbite salve for pharmaceutical purposes
    7. Guaiacol for pharmaceutical purposes
    8. Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations
    9. Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
    10. Injectable pharmaceutical contraceptives
    11. Pharmaceutical anti-allergic preparations and substances
    12. Pharmaceutical for the treatment of erectile dysfunction
    13. Pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations
    14. Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
    15. Pharmaceutical preparations for the treatment of bone fractures
    16. Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
    17. Pharmaceutical preparations for ocular or intraocular surgery
    18. Pharmaceutical preparations for reducing cholesterol
    19. Pharmaceutical preparations for the prevention of osteoporosis
    20. Pharmaceutical preparations for the relief of pain
    21. Pharmaceutical preparations for the treatment of acne
    22. Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections
    23. Pharmaceutical preparations for the treatment of allergies
    24. Pharmaceutical preparations for the treatment of blood disorders
    25. Pharmaceutical preparations for the treatment of cancer
    26. Pharmaceutical preparations for the treatment of cardiovascular diseases
    27. Pharmaceutical preparations for the treatment of carpal tunnel syndrome
    28. Pharmaceutical preparations for the treatment of chronic pain
    29. Pharmaceutical preparations for the treatment of cranial or facial nerve disorders
    30. Pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis
    31. Pharmaceutical preparations for the treatment of dental and oral diseases
    32. Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders
    33. Pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue
    34. Pharmaceutical preparations for the treatment of drug and alcohol abuse
    35. Pharmaceutical preparations for the treatment of gastro-intestinal diseases
    36. Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction
    37. Pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases
    38. Pharmaceutical preparations for the treatment of glaucoma
    39. Pharmaceutical preparations for the treatment of headaches
    40. Pharmaceutical preparations for the treatment of hypercholesteremia
    41. Pharmaceutical preparations for the treatment of hyperlipidemia
    42. Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes
    43. Pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections
    44. Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries
    45. Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases
    46. Pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders
    47. Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely gout, osteoarthritis, muscular dystrophy, anemia
    48. Pharmaceutical preparations for the treatment of metabolic disorders, namely bulimia nervosa, anorexia, and hypothyroidism
    49. Pharmaceutical preparations for the treatment of migraine
    50. Pharmaceutical preparations for the treatment of motion sickness
    51. Pharmaceutical preparations for the treatment of multiple sclerosis
    52. Pharmaceutical preparations for the treatment of myalgia and neuralgia
    53. Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy
    54. Pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders
    55. Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease
    56. Pharmaceutical preparations for the treatment of oncological diseases and disorders
    57. Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders
    58. Pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction
    59. Pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis
    60. Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia
    61. Pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections
    62. Pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne
    63. Pharmaceutical preparations for the treatment of smoking cessation
    64. Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases
    65. Pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease
    66. Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases
    67. Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries
    68. Pharmaceutical preparations for the treatment of the respiratory system
    69. Pharmaceutical preparations for the treatment of varicose veins
    70. Pharmaceutical preparations for the treatment of vascular diseases
    71. Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS)
    72. Pharmaceutical preparations for treating allergic rhinitis and asthma
    73. Pharmaceutical preparations for treating asthma
    74. Pharmaceutical preparations for treating dandruff
    75. Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases
    76. Pharmaceutical preparations for use in discouraging the smoking habit
    77. Pharmaceutical preparations for use in gastroenterology
    78. Pharmaceutical preparations for use in ocular disorders
    79. Pharmaceutical preparations for use in oncology
    80. Pharmaceutical preparations for use in ophthalmology
    81. Pharmaceutical preparations for wounds
    82. Pharmaceutical products and preparations against dry skin caused by pregnancy
    83. Pharmaceutical products and preparations for hydrating the skin during pregnancy
    84. Pharmaceutical products for ophthalmological use
    85. Pharmaceutical products for the treatment of cancer
    86. Pharmaceutical products for treating respiratory diseases
    87. Pharmaceutical solutions used in dialysis
    88. Radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use
    89. Sunburn preparations for pharmaceutical purposes
    90. Synthetic peptides for pharmaceutical purposes
    91. Disinfection systems, namely all-purpose disinfectants..
  • The mark was filed in class 10 with Drug delivery systems, namely needles, syringes, nasal spray bottles, injection devices, oral and nasal inhalation devices, patch pumps, and anesthetic delivery apparatus for medical purposes, but not for use in the fields of diabetes and obesity..
  • The mark was filed in class 35 with Business consulting services relating to pharmaceutical manufacturing, clinical evaluation and testing, regulatory registration, stability studies, method development, formal stability, registration batches and commercial production.
  • The mark was filed in class 40 with Contract manufacturing of clinical batches of pharmaceuticals..
  • The mark was filed in class 42 with Formulation development services, namely the formulation of new dosage forms and the reformulation of existing drug products and clinical trial services, namely managing clinical studies to fast track drug products to market...
  • The mark was filed in class 45 with Consulting services to assist companies with obtaining regulatory compliance and licenses for pharmaceuticals and medical devices..